These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

94 related items for PubMed ID: 1578483

  • 21. Structure-based design of new constrained cyclic agonists of the cholecystokinin CCK-B receptor.
    Blommaert AG, Dhôtel H, Ducos B, Durieux C, Goudreau N, Bado A, Garbay C, Roques BP.
    J Med Chem; 1997 Feb 28; 40(5):647-58. PubMed ID: 9057851
    [Abstract] [Full Text] [Related]

  • 22. Affinity of cholecystokinin receptor antagonists for the gastrin-binding protein.
    Rorison KA, Yang Z, Baldwin GS.
    Eur J Pharmacol; 2000 Jan 24; 388(1):9-15. PubMed ID: 10657541
    [Abstract] [Full Text] [Related]

  • 23. A new probe for affinity labelling pancreatic cholecystokinin receptor with minor modification of its structure.
    Fourmy D, Lopez P, Poirot S, Jimenez J, Dufresne M, Moroder L, Powers SP, Vaysse N.
    Eur J Biochem; 1989 Nov 06; 185(2):397-403. PubMed ID: 2583188
    [Abstract] [Full Text] [Related]

  • 24.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 25. Novel constrained CCK-B dipeptoid antagonists derived from pipecolic acid.
    Bellier B, Da Nascimento S, Meudal H, Gincel E, Roques BP, Garbay C.
    Bioorg Med Chem Lett; 1998 Jun 02; 8(11):1419-24. PubMed ID: 9871777
    [Abstract] [Full Text] [Related]

  • 26.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 27.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 28. Aqueous stability and solubility of CI-988, a novel "dipeptoid" cholecystokinin-B receptor antagonist.
    Kearney AS, Mehta SC, Radebaugh GW.
    Pharm Res; 1992 Aug 02; 9(8):1092-5. PubMed ID: 1409383
    [Abstract] [Full Text] [Related]

  • 29.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 30.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 31. Cyclic cholecystokinin analogues with high selectivity for central receptors.
    Charpentier B, Pelaprat D, Durieux C, Dor A, Reibaud M, Blanchard JC, Roques BP.
    Proc Natl Acad Sci U S A; 1988 Mar 02; 85(6):1968-72. PubMed ID: 3162318
    [Abstract] [Full Text] [Related]

  • 32. Biological properties of the benzodiazepine amidine derivative L-740,093, a cholecystokinin-B/gastrin receptor antagonist with high affinity in vitro and high potency in vivo.
    Patel S, Smith AJ, Chapman KL, Fletcher AE, Kemp JA, Marshall GR, Hargreaves RJ, Ryecroft W, Iversen LL, Iversen SD.
    Mol Pharmacol; 1994 Nov 02; 46(5):943-8. PubMed ID: 7969084
    [Abstract] [Full Text] [Related]

  • 33.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 34.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 35.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 36. Specific binding of D-Tyr25 (Nle28,31)-CCK(25-33) to cortical membranes from rat brain.
    Carlberg M, Jarrott B, Beart PM.
    Neurosci Lett; 1991 Jan 14; 122(1):29-32. PubMed ID: 2057133
    [Abstract] [Full Text] [Related]

  • 37. 5-(Tryptophyl)amino-1,3-dioxoperhydropyrido[1,2-c]pyrimidine-based potent and selective CCK(1)receptor antagonists: structure-activity relationship studies on the substituent at N2-position.
    Bartolomé-Nebreda JM, Patiño-Molina R, Martín-Martínez M, Gómez-Monterrey I, García-López MT, González-Muñiz R, Cenarruzabeitia E, Latorre M, Del Río J, Herranz R.
    J Med Chem; 2001 Jun 21; 44(13):2219-28. PubMed ID: 11405658
    [Abstract] [Full Text] [Related]

  • 38.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 39.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 40.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 5.